Justices Won't Review Drug Exec's $1.4M Tax Penalty
A former pharmaceutical executive lost his last chance to reduce a $1.4 million penalty for failing to report a foreign bank account when the U.S. Supreme Court declined on Tuesday to...To view the full article, register now.
Already a subscriber? Click here to view full article